1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Parenteral Dosage Form Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Parenteral Dosage Form by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Parenteral Dosage Form by Country/Region, 2017, 2022 & 2028 2.2 Parenteral Dosage Form Segment by Type 2.2.1 Emulsions for Injection 2.2.2 Powders for Injection 2.2.3 Gels for Injection 2.3 Parenteral Dosage Form Sales by Type 2.3.1 Global Parenteral Dosage Form Sales Market Share by Type (2017-2022) 2.3.2 Global Parenteral Dosage Form Revenue and Market Share by Type (2017-2022) 2.3.3 Global Parenteral Dosage Form Sale Price by Type (2017-2022) 2.4 Parenteral Dosage Form Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Parenteral Dosage Form Sales by Application 2.5.1 Global Parenteral Dosage Form Sale Market Share by Application (2017-2022) 2.5.2 Global Parenteral Dosage Form Revenue and Market Share by Application (2017-2022) 2.5.3 Global Parenteral Dosage Form Sale Price by Application (2017-2022) 3 Global Parenteral Dosage Form by Company 3.1 Global Parenteral Dosage Form Breakdown Data by Company 3.1.1 Global Parenteral Dosage Form Annual Sales by Company (2020-2022) 3.1.2 Global Parenteral Dosage Form Sales Market Share by Company (2020-2022) 3.2 Global Parenteral Dosage Form Annual Revenue by Company (2020-2022) 3.2.1 Global Parenteral Dosage Form Revenue by Company (2020-2022) 3.2.2 Global Parenteral Dosage Form Revenue Market Share by Company (2020-2022) 3.3 Global Parenteral Dosage Form Sale Price by Company 3.4 Key Manufacturers Parenteral Dosage Form Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Parenteral Dosage Form Product Location Distribution 3.4.2 Players Parenteral Dosage Form Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Parenteral Dosage Form by Geographic Region 4.1 World Historic Parenteral Dosage Form Market Size by Geographic Region (2017-2022) 4.1.1 Global Parenteral Dosage Form Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Parenteral Dosage Form Annual Revenue by Geographic Region 4.2 World Historic Parenteral Dosage Form Market Size by Country/Region (2017-2022) 4.2.1 Global Parenteral Dosage Form Annual Sales by Country/Region (2017-2022) 4.2.2 Global Parenteral Dosage Form Annual Revenue by Country/Region 4.3 Americas Parenteral Dosage Form Sales Growth 4.4 APAC Parenteral Dosage Form Sales Growth 4.5 Europe Parenteral Dosage Form Sales Growth 4.6 Middle East & Africa Parenteral Dosage Form Sales Growth 5 Americas 5.1 Americas Parenteral Dosage Form Sales by Country 5.1.1 Americas Parenteral Dosage Form Sales by Country (2017-2022) 5.1.2 Americas Parenteral Dosage Form Revenue by Country (2017-2022) 5.2 Americas Parenteral Dosage Form Sales by Type 5.3 Americas Parenteral Dosage Form Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Parenteral Dosage Form Sales by Region 6.1.1 APAC Parenteral Dosage Form Sales by Region (2017-2022) 6.1.2 APAC Parenteral Dosage Form Revenue by Region (2017-2022) 6.2 APAC Parenteral Dosage Form Sales by Type 6.3 APAC Parenteral Dosage Form Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Parenteral Dosage Form by Country 7.1.1 Europe Parenteral Dosage Form Sales by Country (2017-2022) 7.1.2 Europe Parenteral Dosage Form Revenue by Country (2017-2022) 7.2 Europe Parenteral Dosage Form Sales by Type 7.3 Europe Parenteral Dosage Form Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Parenteral Dosage Form by Country 8.1.1 Middle East & Africa Parenteral Dosage Form Sales by Country (2017-2022) 8.1.2 Middle East & Africa Parenteral Dosage Form Revenue by Country (2017-2022) 8.2 Middle East & Africa Parenteral Dosage Form Sales by Type 8.3 Middle East & Africa Parenteral Dosage Form Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Parenteral Dosage Form 10.3 Manufacturing Process Analysis of Parenteral Dosage Form 10.4 Industry Chain Structure of Parenteral Dosage Form 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Parenteral Dosage Form Distributors 11.3 Parenteral Dosage Form Customer 12 World Forecast Review for Parenteral Dosage Form by Geographic Region 12.1 Global Parenteral Dosage Form Market Size Forecast by Region 12.1.1 Global Parenteral Dosage Form Forecast by Region (2023-2028) 12.1.2 Global Parenteral Dosage Form Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Parenteral Dosage Form Forecast by Type 12.7 Global Parenteral Dosage Form Forecast by Application 13 Key Players Analysis 13.1 Ashland 13.1.1 Ashland Company Information 13.1.2 Ashland Parenteral Dosage Form Product Offered 13.1.3 Ashland Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Ashland Main Business Overview 13.1.5 Ashland Latest Developments 13.2 Tepnel Pharma Services 13.2.1 Tepnel Pharma Services Company Information 13.2.2 Tepnel Pharma Services Parenteral Dosage Form Product Offered 13.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Tepnel Pharma Services Main Business Overview 13.2.5 Tepnel Pharma Services Latest Developments 13.3 Ascendia Pharmaceuticals 13.3.1 Ascendia Pharmaceuticals Company Information 13.3.2 Ascendia Pharmaceuticals Parenteral Dosage Form Product Offered 13.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Ascendia Pharmaceuticals Main Business Overview 13.3.5 Ascendia Pharmaceuticals Latest Developments 13.4 Thermo Fisher Scientific 13.4.1 Thermo Fisher Scientific Company Information 13.4.2 Thermo Fisher Scientific Parenteral Dosage Form Product Offered 13.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Thermo Fisher Scientific Main Business Overview 13.4.5 Thermo Fisher Scientific Latest Developments 13.5 ProJect Pharmaceutics 13.5.1 ProJect Pharmaceutics Company Information 13.5.2 ProJect Pharmaceutics Parenteral Dosage Form Product Offered 13.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 ProJect Pharmaceutics Main Business Overview 13.5.5 ProJect Pharmaceutics Latest Developments 13.6 Lonza 13.6.1 Lonza Company Information 13.6.2 Lonza Parenteral Dosage Form Product Offered 13.6.3 Lonza Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Lonza Main Business Overview 13.6.5 Lonza Latest Developments 13.7 BOC Sciences 13.7.1 BOC Sciences Company Information 13.7.2 BOC Sciences Parenteral Dosage Form Product Offered 13.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 BOC Sciences Main Business Overview 13.7.5 BOC Sciences Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Parenteral Dosage Form Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Parenteral Dosage Form Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Emulsions for Injection Table 4. Major Players of Powders for Injection Table 5. Major Players of Gels for Injection Table 6. Global Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton) Table 7. Global Parenteral Dosage Form Sales Market Share by Type (2017-2022) Table 8. Global Parenteral Dosage Form Revenue by Type (2017-2022) & ($ million) Table 9. Global Parenteral Dosage Form Revenue Market Share by Type (2017-2022) Table 10. Global Parenteral Dosage Form Sale Price by Type (2017-2022) & (US$/Ton) Table 11. Global Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton) Table 12. Global Parenteral Dosage Form Sales Market Share by Application (2017-2022) Table 13. Global Parenteral Dosage Form Revenue by Application (2017-2022) Table 14. Global Parenteral Dosage Form Revenue Market Share by Application (2017-2022) Table 15. Global Parenteral Dosage Form Sale Price by Application (2017-2022) & (US$/Ton) Table 16. Global Parenteral Dosage Form Sales by Company (2020-2022) & (Kiloton) Table 17. Global Parenteral Dosage Form Sales Market Share by Company (2020-2022) Table 18. Global Parenteral Dosage Form Revenue by Company (2020-2022) ($ Millions) Table 19. Global Parenteral Dosage Form Revenue Market Share by Company (2020-2022) Table 20. Global Parenteral Dosage Form Sale Price by Company (2020-2022) & (US$/Ton) Table 21. Key Manufacturers Parenteral Dosage Form Producing Area Distribution and Sales Area Table 22. Players Parenteral Dosage Form Products Offered Table 23. Parenteral Dosage Form Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Parenteral Dosage Form Sales by Geographic Region (2017-2022) & (Kiloton) Table 27. Global Parenteral Dosage Form Sales Market Share Geographic Region (2017-2022) Table 28. Global Parenteral Dosage Form Revenue by Geographic Region (2017-2022) & ($ millions) Table 29. Global Parenteral Dosage Form Revenue Market Share by Geographic Region (2017-2022) Table 30. Global Parenteral Dosage Form Sales by Country/Region (2017-2022) & (Kiloton) Table 31. Global Parenteral Dosage Form Sales Market Share by Country/Region (2017-2022) Table 32. Global Parenteral Dosage Form Revenue by Country/Region (2017-2022) & ($ millions) Table 33. Global Parenteral Dosage Form Revenue Market Share by Country/Region (2017-2022) Table 34. Americas Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton) Table 35. Americas Parenteral Dosage Form Sales Market Share by Country (2017-2022) Table 36. Americas Parenteral Dosage Form Revenue by Country (2017-2022) & ($ Millions) Table 37. Americas Parenteral Dosage Form Revenue Market Share by Country (2017-2022) Table 38. Americas Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton) Table 39. Americas Parenteral Dosage Form Sales Market Share by Type (2017-2022) Table 40. Americas Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton) Table 41. Americas Parenteral Dosage Form Sales Market Share by Application (2017-2022) Table 42. APAC Parenteral Dosage Form Sales by Region (2017-2022) & (Kiloton) Table 43. APAC Parenteral Dosage Form Sales Market Share by Region (2017-2022) Table 44. APAC Parenteral Dosage Form Revenue by Region (2017-2022) & ($ Millions) Table 45. APAC Parenteral Dosage Form Revenue Market Share by Region (2017-2022) Table 46. APAC Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton) Table 47. APAC Parenteral Dosage Form Sales Market Share by Type (2017-2022) Table 48. APAC Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton) Table 49. APAC Parenteral Dosage Form Sales Market Share by Application (2017-2022) Table 50. Europe Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton) Table 51. Europe Parenteral Dosage Form Sales Market Share by Country (2017-2022) Table 52. Europe Parenteral Dosage Form Revenue by Country (2017-2022) & ($ Millions) Table 53. Europe Parenteral Dosage Form Revenue Market Share by Country (2017-2022) Table 54. Europe Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton) Table 55. Europe Parenteral Dosage Form Sales Market Share by Type (2017-2022) Table 56. Europe Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton) Table 57. Europe Parenteral Dosage Form Sales Market Share by Application (2017-2022) Table 58. Middle East & Africa Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton) Table 59. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country (2017-2022) Table 60. Middle East & Africa Parenteral Dosage Form Revenue by Country (2017-2022) & ($ Millions) Table 61. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country (2017-2022) Table 62. Middle East & Africa Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton) Table 63. Middle East & Africa Parenteral Dosage Form Sales Market Share by Type (2017-2022) Table 64. Middle East & Africa Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton) Table 65. Middle East & Africa Parenteral Dosage Form Sales Market Share by Application (2017-2022) Table 66. Key Market Drivers & Growth Opportunities of Parenteral Dosage Form Table 67. Key Market Challenges & Risks of Parenteral Dosage Form Table 68. Key Industry Trends of Parenteral Dosage Form Table 69. Parenteral Dosage Form Raw Material Table 70. Key Suppliers of Raw Materials Table 71. Parenteral Dosage Form Distributors List Table 72. Parenteral Dosage Form Customer List Table 73. Global Parenteral Dosage Form Sales Forecast by Region (2023-2028) & (Kiloton) Table 74. Global Parenteral Dosage Form Sales Market Forecast by Region Table 75. Global Parenteral Dosage Form Revenue Forecast by Region (2023-2028) & ($ millions) Table 76. Global Parenteral Dosage Form Revenue Market Share Forecast by Region (2023-2028) Table 77. Americas Parenteral Dosage Form Sales Forecast by Country (2023-2028) & (Kiloton) Table 78. Americas Parenteral Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions) Table 79. APAC Parenteral Dosage Form Sales Forecast by Region (2023-2028) & (Kiloton) Table 80. APAC Parenteral Dosage Form Revenue Forecast by Region (2023-2028) & ($ millions) Table 81. Europe Parenteral Dosage Form Sales Forecast by Country (2023-2028) & (Kiloton) Table 82. Europe Parenteral Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions) Table 83. Middle East & Africa Parenteral Dosage Form Sales Forecast by Country (2023-2028) & (Kiloton) Table 84. Middle East & Africa Parenteral Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions) Table 85. Global Parenteral Dosage Form Sales Forecast by Type (2023-2028) & (Kiloton) Table 86. Global Parenteral Dosage Form Sales Market Share Forecast by Type (2023-2028) Table 87. Global Parenteral Dosage Form Revenue Forecast by Type (2023-2028) & ($ Millions) Table 88. Global Parenteral Dosage Form Revenue Market Share Forecast by Type (2023-2028) Table 89. Global Parenteral Dosage Form Sales Forecast by Application (2023-2028) & (Kiloton) Table 90. Global Parenteral Dosage Form Sales Market Share Forecast by Application (2023-2028) Table 91. Global Parenteral Dosage Form Revenue Forecast by Application (2023-2028) & ($ Millions) Table 92. Global Parenteral Dosage Form Revenue Market Share Forecast by Application (2023-2028) Table 93. Ashland Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 94. Ashland Parenteral Dosage Form Product Offered Table 95. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 96. Ashland Main Business Table 97. Ashland Latest Developments Table 98. Tepnel Pharma Services Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 99. Tepnel Pharma Services Parenteral Dosage Form Product Offered Table 100. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 101. Tepnel Pharma Services Main Business Table 102. Tepnel Pharma Services Latest Developments Table 103. Ascendia Pharmaceuticals Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 104. Ascendia Pharmaceuticals Parenteral Dosage Form Product Offered Table 105. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 106. Ascendia Pharmaceuticals Main Business Table 107. Ascendia Pharmaceuticals Latest Developments Table 108. Thermo Fisher Scientific Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 109. Thermo Fisher Scientific Parenteral Dosage Form Product Offered Table 110. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 111. Thermo Fisher Scientific Main Business Table 112. Thermo Fisher Scientific Latest Developments Table 113. ProJect Pharmaceutics Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 114. ProJect Pharmaceutics Parenteral Dosage Form Product Offered Table 115. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 116. ProJect Pharmaceutics Main Business Table 117. ProJect Pharmaceutics Latest Developments Table 118. Lonza Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 119. Lonza Parenteral Dosage Form Product Offered Table 120. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 121. Lonza Main Business Table 122. Lonza Latest Developments Table 123. BOC Sciences Basic Information, Parenteral Dosage Form Manufacturing Base, Sales Area and Its Competitors Table 124. BOC Sciences Parenteral Dosage Form Product Offered Table 125. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022) Table 126. BOC Sciences Main Business Table 127. BOC Sciences Latest Developments List of Figures Figure 1. Picture of Parenteral Dosage Form Figure 2. Parenteral Dosage Form Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Parenteral Dosage Form Sales Growth Rate 2017-2028 (Kiloton) Figure 7. Global Parenteral Dosage Form Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Parenteral Dosage Form Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Emulsions for Injection Figure 10. Product Picture of Powders for Injection Figure 11. Product Picture of Gels for Injection Figure 12. Global Parenteral Dosage Form Sales Market Share by Type in 2021 Figure 13. Global Parenteral Dosage Form Revenue Market Share by Type (2017-2022) Figure 14. Parenteral Dosage Form Consumed in Hospital Figure 15. Global Parenteral Dosage Form Market: Hospital (2017-2022) & (Kiloton) Figure 16. Parenteral Dosage Form Consumed in Clinic Figure 17. Global Parenteral Dosage Form Market: Clinic (2017-2022) & (Kiloton) Figure 18. Parenteral Dosage Form Consumed in Others Figure 19. Global Parenteral Dosage Form Market: Others (2017-2022) & (Kiloton) Figure 20. Global Parenteral Dosage Form Sales Market Share by Application (2017-2022) Figure 21. Global Parenteral Dosage Form Revenue Market Share by Application in 2021 Figure 22. Parenteral Dosage Form Revenue Market by Company in 2021 ($ Million) Figure 23. Global Parenteral Dosage Form Revenue Market Share by Company in 2021 Figure 24. Global Parenteral Dosage Form Sales Market Share by Geographic Region (2017-2022) Figure 25. Global Parenteral Dosage Form Revenue Market Share by Geographic Region in 2021 Figure 26. Global Parenteral Dosage Form Sales Market Share by Region (2017-2022) Figure 27. Global Parenteral Dosage Form Revenue Market Share by Country/Region in 2021 Figure 28. Americas Parenteral Dosage Form Sales 2017-2022 (Kiloton) Figure 29. Americas Parenteral Dosage Form Revenue 2017-2022 ($ Millions) Figure 30. APAC Parenteral Dosage Form Sales 2017-2022 (Kiloton) Figure 31. APAC Parenteral Dosage Form Revenue 2017-2022 ($ Millions) Figure 32. Europe Parenteral Dosage Form Sales 2017-2022 (Kiloton) Figure 33. Europe Parenteral Dosage Form Revenue 2017-2022 ($ Millions) Figure 34. Middle East & Africa Parenteral Dosage Form Sales 2017-2022 (Kiloton) Figure 35. Middle East & Africa Parenteral Dosage Form Revenue 2017-2022 ($ Millions) Figure 36. Americas Parenteral Dosage Form Sales Market Share by Country in 2021 Figure 37. Americas Parenteral Dosage Form Revenue Market Share by Country in 2021 Figure 38. United States Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 39. Canada Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 40. Mexico Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 41. Brazil Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 42. APAC Parenteral Dosage Form Sales Market Share by Region in 2021 Figure 43. APAC Parenteral Dosage Form Revenue Market Share by Regions in 2021 Figure 44. China Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 45. Japan Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 46. South Korea Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 47. Southeast Asia Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 48. India Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 49. Australia Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 50. Europe Parenteral Dosage Form Sales Market Share by Country in 2021 Figure 51. Europe Parenteral Dosage Form Revenue Market Share by Country in 2021 Figure 52. Germany Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 53. France Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 54. UK Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 55. Italy Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 56. Russia Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 57. Middle East & Africa Parenteral Dosage Form Sales Market Share by Country in 2021 Figure 58. Middle East & Africa Parenteral Dosage Form Revenue Market Share by Country in 2021 Figure 59. Egypt Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 60. South Africa Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 61. Israel Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 62. Turkey Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 63. GCC Country Parenteral Dosage Form Revenue Growth 2017-2022 ($ Millions) Figure 64. Manufacturing Cost Structure Analysis of Parenteral Dosage Form in 2021 Figure 65. Manufacturing Process Analysis of Parenteral Dosage Form Figure 66. Industry Chain Structure of Parenteral Dosage Form Figure 67. Channels of Distribution Figure 68. Distributors Profiles